AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Micafungin Sodium Equivalent To Micafungin

10 registrations across 1 African market— 10 active

Markets with Micafungin Sodium Equivalent To Micafungin

Recent registrations

Brand / ProductMarketHolderStatusExpires
PLASULCA 50 mg🇿🇦South AfricaPharmacare Limited û WoodmeadactiveFeb 2030
PLASULCA 100 mg🇿🇦South AfricaPharmacare Limited û WoodmeadactiveFeb 2030
MICONONIN 50 mg🇿🇦South AfricaKAHMA BIOTECH (Pty) LtdactiveMar 2029
MICONONIN 100 mg🇿🇦South AfricaKAHMA BIOTECH (Pty) LtdactiveMar 2029
LEVUSPOZ 50🇿🇦South AfricaRanbaxy Pharmaceutical (Pty) LtdactiveJul 2028
LEVUSPOZ 100🇿🇦South AfricaRanbaxy Pharmaceutical (Pty) LtdactiveJul 2028
MICAFUNGIN 50 SANDOZ🇿🇦South AfricaSandoz South Africa (Pty) LtdactiveJun 2028
MICAFUNGIN 100 SANDOZ🇿🇦South AfricaSandoz South Africa (Pty) LtdactiveJun 2028
MICAFUNGIN 50mg ADCO🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdactiveMay 2028
MICAFUNGIN 100 mg ADCO🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdactiveMay 2028

Micafungin Sodium Equivalent To Micafungin in Africa — Regulatory Overview

Micafungin Sodium Equivalent To Micafungin is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.